BLOCKCHAIN

China’s Central Bank to Inject $4.7M into Blockchain Trade Platform

[ad_1] The People’s Bank of China (PBoC) has secured $4.7 million in funding from China’s central government for its blockchain trade finance platform. The funding will be administered over three years and has been designated for research and development projects.The blockchain platform was initially revealed by the PBoC in Shenzhen during September 2018. The platform is intended to facilitate transfers and create an untamperable ledger for secure information sharing between
BLOCKCHAIN

Ethereum-Based Card Game from Horizon Raises $5 Million

[ad_1] Companies designing digital trading cards and online games are continuing to show their ability to rake in the big bucks in the blockchain world.According to TechCrunch, Horizon Blockchain Games raised $5 million in capital for their game SkyWeaver. The principal investors included Initialized Capital, with additional funds from Regah Ventures, ConsenSys, Digital Currency Group, Polychain Capital, Golden Ventures, and CMT Digital. This investment is an extension of a 2019
Business

Bitcoin Price Loses $8K, Oil -30%, DOW Futures Plunge

[ad_1] Bitcoin (BTC) closed the week at $8,024, a shocking 9.92% loss and a new weekly low not seen since January 13 when the asset traded for $7,946. The abrupt correction took place as DOW, S&P 500 and oil futures plummeted as investor fears over the economic impact of the coronavirus continue to intensify. Crypto market daily price chart. Source: Coin360Coronavirus fears grip the global economyDow futures dropped more than 1,200
BLOCKCHAIN

Nippon Express Developing Blockchain Transport Network

[ad_1] A Japanese logistics company is planning to incorporate a blockchain network into a new transportation system to be developed next year.According to an article from the Nikkei newspaper, Nippon Express plans to invest up to 100 billion yen — approximately one billion USD — into a blockchain-based transportation network for pharmaceuticals. The Tokyo-based company intends to develop its own line of drugs starting in 2021, which will require real-time